At LED Dental, we are driven by a singular mission: to empower dental professionals with cutting-edge technology that improves lives. As the creators of the award-winning VELscope®, we’ve pioneered a revolution in oral cancer screening—bringing clarity, confidence, and early detection to the forefront of clinical care.
Founded as a subsidiary of LED Medical Diagnostics Inc., LED Dental has remained steadfast in its commitment to delivering science-backed, non-invasive diagnostic tools that are easy to use, clinically powerful, and trusted by thousands of practices worldwide. Our flagship device, the VELscope, has become a global standard for enhanced oral tissue visualization, aiding in the early detection of oral cancer and other mucosal abnormalities.
What sets us apart is not just our technology, but our belief in proactive prevention. We work hand-in-hand with dental professionals, educators, and researchers to expand awareness of oral cancer’s growing threat and provide practical tools that elevate the standard of care.
Innovation – Constantly improving our products to meet the evolving needs of modern dental care.
Education – Equipping providers with the training and confidence to screen more effectively.
Access – Making life-saving technology available to as many patients as possible.
Integrity – Ensuring accuracy, reliability, and clinical value in every product we develop.
With a history rooted in optical imaging expertise and a future aimed at broader diagnostic impact, LED Dental is proud to be a trusted partner in the fight against oral disease.
The VELscope system is a powerful, fluorescence-based device that enhances the visualization of oral mucosal abnormalities such as oral cancer and premalignant dysplasia. Unlike other adjunctive devices used by dentists, the VELscope system does not require any dyes or prolonged testing procedures. In fact, VELscope examinations can be performed in the dentist’s office during routine hygiene exams.
The VELscope Enhanced Oral Assessment System is centered on a handheld scope that is used by clinicians to illuminate oral tissues with blue light and visualize the resulting natural tissue fluorescence. This fluorescence enhances the traditional oral examination by allowing visualization of abnormal areas that may not have been apparent or even visible to the naked eye.
The VELscope system is an adjunctive device which means it must be used together with and as a supplement to the traditional intra and extraoral head and neck exam. Unlike other adjunctive devices used for oral examinations, the VELscope does not require any dyes or prolonged testing procedures. In fact, a VELscope exam can be performed in the dentist’s office during a routine hygiene exam in about two minutes.
Whether you begin your journey on our courses website or choose the flexibility of video learning, our courses are designed to help you along your path.
VELscope technology is changing the way oral mucosal examinations take place. The VELscope handheld device emits a harmless, bright blue light which is used to inspect the mouth and tongue. The device is sensitive to abnormal tissue changes and the distinctive blue-spectrum light causes the soft tissue (oral mucosa) of the mouth to naturally fluoresce. Healthy tissues fluoresce in distinct patterns that may be visibly disrupted when tissue undergoes an abnormal change (which can occur in the oral mucosa for a multitude of reasons) such as when associated with dysplasia or oral cancer.
Dental practices use the VELscope device to supplement the comprehensive oral exam (“COE”, also referred to as an intra and extraoral head and neck exam), and they are rapidly embracing the use of this device to help visualize abnormal oral tissue such as cancerous or pre-cancerous tissues that are sometimes not apparent or even visible to the naked eye. This enhanced examination increases the chance that all suspicious areas are identified so that they can be investigated to establish an appropriate diagnostic or treatment protocol and rule out serious pathology like dysplasia or cancer.
The statistics are highly suggestive: when discovered early the 5-year relative survival rate for oral cancer patients is about 83%. Unfortunately, most cases of oral cancer are discovered in late stages when the five-year relative survival rate drops to around 40 percent. Using the VELscope in everyday practice facilitates early discovery of abnormalities and increases the chance of a better prognosis for the patient should biopsy confirm the presence of dysplasia or cancer.
New research confirms that the risk factors for oral cancer have been expanded to include exposure to the Human Papilloma Virus (HPV16), in addition to tobacco use, frequent and/or excessive alcohol consumption, a compromised immune system, and past history of cancer. This changing demographic presents an unprecedented call to action for oral cancer awareness and regular screenings.
2015 “Best of Class” Technology Award
Category: Diagnostics
The Pride Institute
June, 9 2015
2013-14 “Best of Class” Technology Award
Category: Diagnostics
The Pride Institute
July 22, 2013
Top 100 Products of 2013
Dentistry Today
July 12, 2013
2012 “Best of Class” Technology Award
Category: Diagnostics
The Pride Institute
October 18, 2012
Best New Diagnostic/Imaging Device
2012 Dental Excellence Awards
DrBicuspid.com
January 24, 2012
2011 “Best of Class” Technology Award
Category: Diagnostics
The Pride Institute
October 10, 2011
Top 100 Products of 2011
Dentistry Today
July 07, 2011
World Health Organization
2010 Recognition
World Health Organization
June 30, 2010
Red Herring Canada 50
LED Medical Diagnostics Inc. receives award for innovation and promise.
Red Herring
September 19, 2008
Reality Publishing Award
Category: Most Unique “First Look” Product
Reality Magazine
November 13, 2007
CAUTION: VELscope Vx system to be operated only with external power brick provided with the system: MENB1060A1200F03 (SL Power).
Physical
Electrical
Optical
Environmental
